BIRMINGHAM, Ala., March 16 /PRNewswire-FirstCall/ -- Emageon Inc. , a leading provider of enterprise-level intelligent visual medical systems to hospitals and healthcare networks, announced today that its quality management system has received ISO 13485:2003 certification from the certification body, Lloyd's Register Quality Assurance (LRQA), for both the Madison, WI and Birmingham, AL offices. The certificate issued is for the design and management of software manufacturing and for services used by healthcare provider organizations for the clinical analysis, management, storage, distribution and visualization of digital medical images and corresponding data.

"Emageon's quality system is a fundamental part of our mission," said Chuck Jett, Emageon's Chairman and CEO. "We invest heavily in our quality system because it's good for both our customers and our business. Emageon takes pride in our ISO 13485:2003 certification and welcomes the ongoing vigilance the accreditation body will bring to our quality process."

About ISO

ISO is a network of the national standards institutes of 148 countries, on the basis of one member per country, with a Central Secretariat in Geneva, Switzerland, that coordinates the system. The primary objective of ISO 13485:2003 is to facilitate harmonized medical device regulatory requirements for quality management systems. For more information, please visit http://www.iso.org/ .

About Emageon Inc.

Emageon's Intelligent Visual Medical System(TM) (IVMS) is an enterprise- level advanced visualization and infrastructure solution that allows physicians and healthcare professionals to manage, access and visualize medical content using relevant multi-specialty tools through a dynamic user interface. Delivered through Emageon's Enterprise Platform, hospital networks, clinics and imaging facilities are able to deploy a functionally rich, standards-based technology that permits faster access to future innovation while helping to lower the total cost of ownership. Emageon's approach to the enterprise-wide delivery of better tools, software and services is designed to improve customer results and enhance patient care. For more information, please visit http://www.emageon.com/ .

This press release contains forward-looking statements about Emageon which represent the Company's current views with respect to, among other things, future events and financial performance. Any forward-looking statements contained in this press release are based on Emageon's historical performance and on current plans, beliefs and expectations. Actual results may differ materially from those expressed or implied by such forward-looking statements as a result of various risks, uncertainties and other factors beyond our control. These risks, uncertainties and other factors include, among others, the risk that the Company may not compete successfully against other industry competitors, some of whom are substantially larger than Emageon, risks associated with the timing of customer contracts and the related revenue, the risk that the Company may not manage its growth effectively, risks associated with Emageon's reliance on continuing relationships with large customers, the risk of significant product errors or product failures, risks associated with potential acquisitions, including integration difficulties, dilution or other adverse financial consequences, and the potential impact of FDA regulations and other potentially applicable health care regulations. Additional information concerning these and other factors that could affect Emageon's financial results may be found under the heading "Risk Factors" and elsewhere in the Company's final prospectus filed with the Securities and Exchange Commission on February 9, 2005. Emageon undertakes no obligation to update these forward-looking statements or any other information provided in this press release except as may be required by law.

CONTACT: Bill Funderburk of Emageon, +1-205-980-7542, or
bill.funderburk@emageon.com

Web site: http://www.emageon.com/
http://www.iso.org/